WebBioSuperior Technology. Business Services · California, United States · <25 Employees . For biotech and pharma companies that have research or preclinical protein therapeutic … WebJun 17, 2024 · Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 1. Total Funding Amount $256K. Lead Investors 1. Investors 1. ... BioSuperior has raised a total of $256K in funding over 1 round. This was a Grant round raised on Jun 17, 2024. Which funding types raised the most money?
BioSuperior Technology, Inc (@BioSuperiorTech) / Twitter
WebBioSuperior Technology, Inc. is a preclinical stage biotherapeutics company developing e˜ective treatment for serious lung illness. Our mission is to revolutionize pulmonary care and save lives by curing lung disease. FastStats - Leading Causes of Death (cdc.gov) #1 BioSurf Bioengineered lung surfactant for delivery of Web10 BioSuperior Technology, Inc. 2024 FAQs Why is now a good time to invest in the pulmonary care industry and BioSuperior? New lung pathogens (e.g., COVID variants) and environmental problems (e.g., smoke inhalation from wildfires, military burn pits, etc.) will continue to increase the number of patients with serious lung illness. is ended a preposition
Russ Lehrman - President - BioSuperior Technology
Web1 day ago · FPI-2068 is a targeted alpha therapy (TAT) designed to deliver actinium-225 to various solid tumors that express EGFR and cMET. EGFR and cMET are both validated targets that are co-expressed in multiple tumor types, including head and neck squamous cell carcinoma, non-small cell lung cancer, colorectal cancer, and pancreatic ductal … WebBioSuperior Technology, Inc. is testing the waters to evaluate investor interest. No money or other consideration is being solicited; if sent, it will not be accepted. No offer to buy … WebApr 12, 2024 · See new Tweets. Conversation ryanair 737 cockpit